Radical generation and alterations of erythrocyte integrity as bioindicators of diagnostic or prognostic value in COPD?

Antioxidants and Redox Signaling

Volumn 10, Issue 4, 2008, Pages 829-836

  Minetti, Maurizio ^a   Leto, Thomas L ^b   Malorni, Walter ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CARBONYL DERIVATIVE; ETHANE; GLUTATHIONE PEROXIDASE; GLYCOPHORIN; ISOPROSTANE DERIVATIVE; MALONALDEHYDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; POTASSIUM; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RUBIDIUM; SELENIUM; SUPEROXIDE DISMUTASE; THIOL;

CELL FUNCTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIAGNOSTIC PROCEDURE; ERYTHROCYTE; HUMAN; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SMOKING;

ERYTHROCYTES; HUMANS; MODELS, BIOLOGICAL; OXIDATION-REDUCTION; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 38949161959     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2007.1864     Document Type: Review

References (69)

1. Alp S, Skrygan M, Schmidt WE, and Bastian A. Sildenafil improves hemodynamic parameters in COPD: an investigation of six patients. Pulm Pharmacol Ther 19: 386-390, 2006.
2. Arif E, Ahsan A, Vibhuti A, Rajput C, Deepak D, Athar M, Singh B, and Pasha MA. Endothelial nitric oxide synthase gene variants contribute to oxidative stress in COPD. Biochem Biophys Res Commun 361: 182-188, 2007.
3. Asada M, Yamaya M, Ebihara S, Yasuda H, Tomita N, Kubo H, and Sasaki H. Interleukin-1beta gene polymorphisms associated with COPD. Chest 128: 1072-1073, 2005
4. Balasubramanian VP and Varkey B. Chronic obstructive pulmonary disease: effects beyond the lungs. Curr Opin Pulm Med 12: 106-112, 2006.
5. Barcelo B, Pons J, Fuster A, Sauleda J, Noguera A, Ferrer JM, and Agusti AG. Intracellular cytokine profile of T lymphocytes in patients with chronic obstructive pulmonary disease. Clin Exp Immunol 145: 474-479, 2006.
6. Barnes PJ, Shapiro SD, and Pauwels RA. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J 22: 672-688, 2003.
7. Barreiro E, Gea J, Corominas JM, and Hussain SN. Nitric oxide synthase and protein oxidation in the quadriceps femoris of patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 29: 771-778, 2003.
8. Brindicci C, Ito K, Resta O, Pride NB, Barnes PJ, and Kharitonov SA. Exhaled nitric oxide from lung periphery is increased in COPD. Eur Respir J 26: 52-59, 2005.
9. Camoretti-Mercado B and Solway J. Transforming growth factor-beta1 and disorders of the lung. Cell Biochem Biophys 43: 131-148, 2005.
10. Celli BR and Barnes PJ. Exacerbations of chronic obstructive pulmonary disease. Eur Respir J 29: 1224-1238, 2007.
11. Chan-Yeung M, Ho SP, Cheung AH, So LK, Wong PC, Chan KK, Chan JW, Ip MS, and Mak JC. Polymorphisms of glutathione S-transferase genes and functional activity in smokers with or without COPD. Int J Tuberc Lung Dis 11: 508-514, 2007.
12. Chavez J, Cano C, Souki A, Bermudez V, Medina M, Ciszek A, Amell A, Vargas ME, Reyna N, Toledo A, Cano R, Suarez G, Contreras F, Israili ZH, Hernandez-Hernandez R, and Valasco M. Effect of cigarette smoking on the oxidant/antioxidant balance in healthy subjects. Am J Ther 14: 189-193, 2007.
13. De Castro J, Hernàndez-Hernàndez A, Rodriguez MC, Sardina JL, Llanillo M, and Sànchez-Yagüe J. Comparison of changes in erythrocyte and platelet phospholipid and fatty acid composition and protein oxidation in chronic obstructive pulmonary disease and asthma. Platelets 18: 43-51, 2007
14. Dietrich M, Block G, Benowitz NL, Morrow JD, Hudes M, Jacob P 3rd, Norkus EP, and Packer L. Vitamin C supplementation decreases oxidative stress biomarker f2-isoprostanes in plasma of nonsmokers exposed to environmental tobacco smoke. Nutr Cancer 45: 176-184, 2003.
15. Drost EM, Selby C, Bridgeman MM, and MacNee W. Decreased leukocyte deformability after acute cigarette smoking in humans. Am Rev Respir Dis 148: 1277-1283, 1993.
16. Elias JA, Zheng T, Lee CG, Homer RJ, Chen Q, Ma B, Blackburn M, and Zhu Z. Transgenic modeling of interleukin-13 in the lung. Chest 123: 339S-345S, 2003.
17. Florek E, Ignatowicz E, Wrzosek J, and Piekoszewski W. Effect of rutin on total antioxidant status of rats exposed to cigarette smoke. Pharmacol Rep 57: 84-89, 2005.
18. Fu WP, Zhao ZH, Fang LZ, Sun C, Liu L, Zhang JQ, Zhang YP, and Dai LM. Heme oxygenase-1 polymorphism associated with severity of chronic obstructive pulmonary disease. Chin Med J 120: 12-16, 2007.
19. Geiszt M, Witta J, Baffi J, Lekstrom K, and Leto TL. Dual oxidases represent novel hydrogen peroxide sources supporting mucosal surface host defense. FASEB J 17: 1502-1504, 2003.
20. Hansel TT, Kharitonov SA, Donnelly LE, Erin EM, Currie MG, Moore WM, Manning PT, Recker DP, and Barnes PJ. A selective inhibitor of inducible nitric oxide synthase inhibits exhaled breath nitric oxide in healthy volunteers and asthmatics. FASEB J 17: 1298-1300, 2003.
21. Harper RW, Xu C, Eiserich JP, Chen Y, Kao CY, Thai P, Setiadi H, and Wu R. Differential regulation of dual NADPH oxidases/peroxidases, Duox1 and Duox2, by Th1 and Th2 cytokines in respiratory tract epithelium. FEBS Lett 579: 4911-4917, 2005.
22. Hemalatha A, Venkatesan A, Bobby Z, Selvaraj N, and Sathiyapriya V. Antioxidant response to oxidative stress induced by smoking. Indian J Physiol Pharmacol 50: 416-420, 2006.
23. Henson PM, Vandivier RW, and Douglas IS. Cell death, remodeling, and repair in chronic obstructive pulmonary disease? Proc Am Thorac Soc 3:713-717, 2006.
24. Ishii Y, Itoh K, Morishima Y, Kimura T, Kiwamoto T, Iizuka T, Hegab AE, Hosoya T, Nomura A, Sakamoto T, Yamamoto M, and Sekizawa K. Transcription factor Nrf2 plays a pivotal role in protection against elastase-induced pulmonary inflammation and emphysema. J Immunol 175: 6968-6972, 2005.
25. Isik B, Ceylan A, and Isik R. Oxidative stress in smokers and non-smokers. Inhal Toxicol 19: 767-769, 2007.
26. Joppa P, Petrasova D, Stancak B, Dorkova Z, and Tkacova R. Oxidative stress in patients with COPD and pulmonary hypertension. Wien Klin Wochenschr 119: 428-434, 2007.
27. Kassim SY, Fu X, Liles WC, Shapiro SD, Parks WC, and Heinecke JW. NADPH oxidase restrains the matrix metalloproteinase activity of macrophages. J Biol Chem 280: 30201-30205, 2005.
28. Lambeth JD. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 4: 181-189, 2004.
29. Landgraf H, Ehrly AM, Saeger-Lorenz K, and Fischer G. Erythrocyte filtration and smoking. Scand J Clin Lab Invest Suppl 156: 199-201, 1981.
30. Lassegue B and Clempus RE. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol 285: R277-R297, 2003.
31. Leto TL and Geiszt M. Role of Nox family NADPH oxidases in host defense. Antioxid Redox Signal 8: 1549-1561, 2006.
32. Lucantoni G, Pietraforte D, Matarrese P, Gambardella L, Metere A, Paone G, Bianchi EL, and Straface E. The red blood cell as a biosensor for monitoring oxidative imbalance in chronic obstructive pulmonary disease: an ex vivo and in vitro study. Antioxid Redox Signal 8: 1171-1182, 2006.
33. Ludwig PW and Hoidal JR. Alterations in leukocyte oxidative metabolism in cigarette smokers. Am Rev Respir Dis 126: 977-980, 1982.
34. MacNee W and Rahman I. Is oxidative stress central to the pathogenesis of chronic obstructive pulmonary disease? Trends Mol Med 7: 57-62, 2001.
35. Mak JC, Ho SP, Yu WC, Choo KL, Chu CM, Yew WW, Lam WK, and Chan-Yeung M, on behalf of the Hong Kong Thoracic Society Chronic Obstructive Pulmonary Disease Study Group. Polymorphisms and functional activity in superoxide dismutase and catalase genes in smokers with COPD. Eur Respir J 30: 684-690, 2007.
36. Matarrese P, Straface E, Pietraforte D, Gambardella L, Vona R, Maccaglia A, Minetti M, and Malorni W. Peroxynitrite induces senescence and apoptosis of red blood cells through the activation of aspartyl and cysteinyl proteases. FASEB J 19: 416-418, 2005.
37. Michaud SE, Dussault S, Haddad P, Groleau J, and Rivard A. Circulating endothelial progenitor cells from healthy smokers exhibit impaired functional activities. Atherosclerosis 187: 423-432, 2006.
38. Minetti M and Malorni W. Redox control of red blood cell biology: the red blood cell as a target and source of prooxidant species. Antioxid Redox Signal 8: 1165-1169, 2006.
39. Minetti M, Agati L, and Malorni W. The microenvironment can shift erythrocytes from a friendly to a harmful behavior: pathogenetic implications for vascular diseases. Cardiovasc Res 75: 21-28, 2007.
40. Montuschi P, Collins JV, Ciabattoni G, Lazzeri N, Corradi M, Kharitonov SA, and Barnes PJ. Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am J Respir Crit Care Med 162: 1175-1177, 2000.
41. Moskwa P, Lorentzen D, Excoffon KJ, Zabner J, McCray PB Jr, Nauseef WM, Dupuy C, and Banfi B. A novel host defense system of airways is defective in cystic fibrosis. Am J Respir Crit Care Med 175: 174-183, 2007.
42. Mullick AE, McDonald JM, Melkonian G, Talbot P, Pinkerton KE, and Rutledge JC. Reactive carbonyls from tobacco smoke increase arterial endothelial layer injury. Am J Physiol Heart Circ Physiol 283: H591-H597, 2002.
43. Nadeem A, Raj HG, and Chhabra SK. Increased oxidative stress and altered levels of antioxidants in chronic obstructive pulmonary disease. Inflammation 29: 23-32, 2005.
44. Paredi P, Kharitonov SA, Leak D, Ward S, Cramer D, and Barnes PJ. Exhaled ethane, a marker of lipid peroxidation, is elevated in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 162: 369-373, 2000.
45. Petruzzelli S, Puntoni R, Mimotti P, Pulerã N, Baliva F, Fornai E, and Giuntini C. Plasma 3-nitrotyrosine in cigarette smokers. Am J Respir Crit Care Med 156: 1902-1907, 1997.
46. Pietraforte D, Matarrese P, Straface E, Gambardella L, Metere A, Scorza G, Leto TL, Malorni W, and Minetti M. Two different pathways are involved in peroxynitrite-induced senescence and apoptosis of human erythrocytes. Free Radic Biol Med 42: 202-214, 2007.
47. Pignatelli B, Li CQ, Boffetta P, Chen Q, Ahrens W, Nyberg F, Mukeria A, Bruske-Hohlfeld I, Fortes C, Constantinescu V, Ischiropoulos H, and Ohshima H. Nitrated and oxidized plasma proteins in smokers and lung cancer patients. Cancer Res 61: 778-784, 2001.
48. Pryor W and Stone K. Oxidants in cigarette smoke radicals, hydrogen peroxides, peroxynitrate, and peroxynitrite. Ann N Y Acad Sci 28: 12-27, 1993.
49. Rahman I and Kilty I. Antioxidant therapeutic targets in COPD. Curr Drug Targets 7: 707-720, 2006.
50. Rahman I, Morrison D, Donaldson K, and MacNee W. Systemic oxidative stress in asthma, COPD and smokers. Am J Respir Crit Care Med 154: 1055-1060, 1996.
51. Redington AE. Modulation of nitric oxide pathways: therapeutic potential in asthma and chronic obstructive pulmonary disease. Eur J Pharmacol 533: 263-276, 2006.
52. Ricciardolo FL, Di Stefano A, Sabatini F, and Folkerts G. Reactive nitrogen species in the respiratory tract. Eur J Pharmacol 533: 240-252, 2006.
53. Rogowski O, Berliner S, Zeltser D, Serov J, Ben-Assayag E, Justo D, Rozenblat M, Kessler A, Deutsch V, Zakuth V, and Shapira I. The erythrosense as a real-time biomarker to reveal the presence of enhanced red blood cell aggregability in atherothrombosis. Am J Ther 12: 286-292, 2005.
54. Santini MT, Straface E, Cipri A, Peverini M, Santulli M, Malorni W. Structural alterations in erythrocytes from patients with chronic obstructive pulmonary disease. Haemostasis 27: 201-210, 1997.
55. Santos MC, Oliveira AL, Viegas-Crespo AM, Vicente L, Barreiros A, Monteiro P, Pinheiro T, and Bugalho de Almeid A. Systemic markers of the redox balance in chronic obstructive pulmonary disease. Biomarkers 9: 461-469, 2004.
56. Schafroth Torok S and Leuppi JD. Bronchial hyper-responsiveness and exhaled nitric oxide in chronic obstructive pulmonary disease. Swiss Med Wkly 137: 385-391, 2007.
57. Sin DD and Man SF. Systemic inflammation and mortality in chronic obstructive pulmonary disease. Can J Physiol Pharmacol 85: 141-147, 2007.
58. Sobczak A, Wardas W, Zielinska-Danch W, and Pawlicki K. The influence of smoking on plasma homocysteine and cysteine levels in passive and active smokers. Clin Chem Lab Med 42: 408-814, 2004.
59. Straface E, Matarrese P, Gambardella L, Forte S, Carlone S, Libianchi E, Schmid G, and Malorni W. N-Acetylcysteine counteracts erythrocyte alterations occurring in chronic obstructive pulmonary disease. Biochem Biophys Res Commun 279: 552-556, 2000.
60. Sturrock A, Huecksteadt TP, Normal K, Sanders K, Murphy TM, Chitano P, Wilson K, Hoidal JR, and Kennedy TP. Nox4 mediates TGF-beta1-induced retinoblastoma protein phosphorylation, proliferation and hypertrophy in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 292: L1543-L1555, 2007.
61. Tzortzaki EG, Lambiri I, Vlachaki E, and Siafakas NM. Biomarkers in COPD. Curr Med Chem 14: 1037-1048, 2007.
62. van Antwerpen VL, Theron AJ, and Richards GA, Steenkamp KJ, van der Merwe CA, van der Walt R, and Anderson R. Vitamin E, pulmonary functions, and phagocyte-mediated oxidative stress in smokers and nonsmokers. Free Radic Biol Med 18: 935-941, 1995.
63. Vibhuti A, Arif E, Deepak D, Singh B, and Qadar Pasha MA. Genetic polymorphisms of GSTP1 and mEPHX correlate with oxidative stress markers and lung function in COPD. Biochem Biophys Res Commun 359: 136-142, 2007.
64. Wang Z, Zheng T, Zhu Z, Homer RJ, Riese RJ, Chapman HA, Shapiro SD, and Elias JA. Interferon gamma induction of pulmonary emphysema in the adult murine lung. J Exp Med 192: 1587-1600, 2000.
65. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, and Donaldson DD. Interleukin-13: central mediator of allergic asthma. Science 282: 2258-2261, 1998.
66. Wynn TA. Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat Rev Immunol 8: 583-594, 2004.
67. Yanbaeva DG, Dentener MA, Creutzberg EC, and Wouters EF. Systemic inflammation in COPD: is genetic susceptibility a key factor? COPD 3: 51-61, 2006.
68. Yanbaeva DG, Dentener MA. Creutzberg EC, Wesseling G, and Wouters EFM. Systemic effects of smoking. Chest 131: 1557-1566, 2007.
69. Zhang X, Shan P, Jiang G, Cohn L, and Lee PJ. Toll-like receptor 4 deficiency causes pulmonary emphysema. J Clin Invest 116: 3050-3059, 2006.